IASO Biotherapeutics
Member of Chinese Academy of Sciences
Director and Professor, Institute for Immunology, Tsinghua University
Fellow of the American Association for the Advancement of Science
The 2009 American Society of Immunologists-BD Biosciences Investigator Award, the 2019 International Cytokine and Interferon Society Biolegend-William E. Paul Award
Specialty Chief Editor for Frontiers in Immunology, T Cell Biology, Associate Chief Editor for China Science Life Sciences, and Editorial Board Member of Immunity
Published more than 200 papers in immunology field, and was recognized as a “Highly Cited Scientist” in the world for seven consecutive years from 2014 to 2020
This person is not in the org chart
This person is not in any offices
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.